Eurofins CRL operates as an ISO 9001:2015, GCP compliant contract laboratory providing a wide range of clinical safety and efficacy testing to the cosmetic, beauty products, personal care, and pharmaceutical industries. Located in central New Jersey, CRL is dedicated to conducting human clinical test procedures to determine the safety and efficacy of cosmetic, personal care, and OTC drug products. The Company focuses its clinical expertise in the areas of dermatology, photobiology, ophthalmology, bioinstrumentation, microbiology, cosmetology, clinical trials, and associated services. ECRL operates a 22,000 square foot clinical testing facility with approximately 75 employees in Piscataway, NJ along with two additional facilities in Winston-Salem, North Carolina and Austin, Texas.

Eurofins CRL was first founded in 1992. The objective in starting the business was to develop a leading independent laboratory for in vivo clinical testing. The Company focused on providing clients with customized safety and efficacy testing programs for consumer and pharmaceutical products. The Company maintains a database containing over 25,000 panelists, each having completed a comprehensive medical history and product usage survey. Eurofins CRL can design clinical trials utilizing over 30 different study-related variables, which include age, race, sex, skin type, and product usage practices using its existing panelist relationships.

Eurofins CRL has completed over 20,000 clinical testing studies for more than 300 different businesses and has established long term contracts with some of the largest consumer products companies in the world. The Company routinely conducts studies for anti-aging claims, SPF efficacy, acne treatment and a variety of other cosmetic product categories. The Company has established a reputation for excellence in clinical studies and testing.

Eurofins CRL performs a wide range of clinical safety and efficacy testing which can be categorized into three primary areas including: (i) Repeated Insult Patch Test (“RIPT”) which is the industry standard for dermal sensitization testing; RIPT is used predominately for skin care products, color cosmetics, woven and non-woven fabrics and fragrances, (ii) In-Use Safety Studies which allow product vendors to make dermatological safety in-use claims such as “Dermatologist Tested” and “Safe for Sensitive Skin” or any other substantive safety claims, and (iii) traditional efficacy and safety assessments that provide results of the efficacy of a particular consumer product and product claim substantiation and authentication.

Eurofins CRL aspires to be the laboratory of choice for in vivo clinical testing. Our management and staff will work individually with each client to develop a customized safety and efficacy testing program that meets the client’s individual study goals within their specific budgetary requirements. We are committed to uncompromising excellence in providing services for clinical trial management.